Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-07-02

Clinical Trial Update: UVA 1 Phototherapy for Vitiligo [Phase 2]

View source ↗

Summary

Phase 2 UVA1 phototherapy trial for vitiligo sponsored by the University of British Columbia; current status is not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of British Columbia | Conditions: Vitiligo | Phase 2 | Status: UNKNOWN